Richard G. Vincent, Chief Financial Officer at Oncternal Therapeutics, Inc. (ONCT), bought 30,000 shares at $0.30 ($9K) on 2023-04-13, disclosed to the SEC on 2023-04-14.
Open-market purchase of $9k ONCT by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Clearly above the average filing.
| Filing → |